Pay in 4 interest-free payments of $5.12 Learn more
Ships within 48 hours · Estimated delivery Oct 8 - Oct 13
Zepbound (tirzepatide) is FDA approved for weight loss and chronic weight management in adults with obesity, as well as adults who are overweight with at least one weight-related medical condition, such as high cholesterol or high blood pressure
The average participant on Wegovy lost 14.9% of their body weight after 68 weeks
Adolescents With Prior Bariatric Surgery Some adolescents initiating tirzepatide have previously undergone sleeve gastrectomy or Roux-en-Y gastric bypass
Lupin is well-positioned to expand its leadership in diabetes care and obesity beyond India with this Semaglutide partnership
The drug accumulates in your body when you take weekly injections consistently, reaching steady-state concentrations after 4 weeks of regular dosing
US$ 29.76
US$ 25.17
US$ 28.57
